Find comprehensive information on the history of liver cancer diagnosis, including relevant healthcare documentation, clinical terminology, and medical coding. Learn about risk factors, staging, diagnostic procedures, and the evolution of liver cancer treatment. This resource provides valuable insights for healthcare professionals, researchers, and patients seeking in-depth knowledge about the history and progression of liver cancer diagnosis. Explore topics such as hepatocellular carcinoma, cholangiocarcinoma, alpha-fetoprotein, liver biopsy, imaging techniques, and historical treatment modalities.
Also known as
Personal history of malignant neoplasm of liver
Indicates a past diagnosis of primary liver cancer.
Liver and intrahepatic bile duct carcinoma
Classifies various types of primary liver cancers for active cases.
Secondary malignant neoplasm of liver
Identifies liver cancer that has spread from another primary site.
Factors influencing health status and contact with health services
Encompasses personal history of various conditions, including cancers.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the liver cancer currently active?
When to use each related code
| Description |
|---|
| Liver cancer |
| Cirrhosis |
| Hepatitis C |
Coding Z85.0 without specifying primary or secondary liver cancer when documented leads to inaccurate data and potential underpayment.
Incorrect sequencing of HCC with metastasis or complications impacts DRG assignment and reimbursement, necessitating CDI query.
Miscoding active liver cancer (C22.x) as history of (Z85.0) or vice versa creates compliance risks and inaccurate cancer registry data.
Patient presents with a history of hepatocellular carcinoma (HCC), diagnosed in [Month, Year]. Initial presentation included [Symptoms, e.g., abdominal pain, fatigue, weight loss]. Diagnostic workup at that time revealed [Imaging findings, e.g., a single hepatic lesion measuring x cm on CT scan, multifocal HCC on MRI], confirmed by [Biopsy findings, e.g., fine-needle aspiration biopsy consistent with HCC]. Alpha-fetoprotein (AFP) level at diagnosis was [Value, e.g., elevated at XXX ngmL]. Staging at the time of diagnosis was [Stage, e.g., Stage I, Barcelona Clinic Liver Cancer (BCLC) Stage A]. Initial treatment consisted of [Treatment, e.g., surgical resection, radiofrequency ablation, transarterial chemoembolization (TACE)]. Patient reports [Current status, e.g., being disease-free, recurrence of HCC]. Current symptoms include [Symptoms, e.g., no symptoms, abdominal discomfort, jaundice]. Physical examination reveals [Findings, e.g., a well-healed surgical scar, palpable liver mass, splenomegaly]. Laboratory findings include [Lab values, e.g., liver function tests, AFP level]. Imaging studies [Specify imaging modality, e.g., CT abdomen, MRI liver] demonstrate [Findings, e.g., no evidence of disease, recurrent tumor in the liver]. Assessment: History of liver cancer (HCC), [Current status, e.g., in remission, with recurrence]. Plan: [Plan of care, e.g., continued surveillance with imaging and AFP levels, referral to oncology for consideration of [Treatment options, e.g., systemic therapy, liver transplant evaluation]]. Patient education provided regarding HCC prognosis, treatment options, and importance of follow-up care. ICD-10 code: C22.0 (Liver cell carcinoma) and Z85.010 (Personal history of malignant neoplasm of liver, primary).